Largely through the research of a group of pathologists, in recent years, it has become evident that the most distinctive component of this tumor is immunoreactivity for HMB-45.9 Up to 52% of patients with angiomyolipomas larger than 4 cm were symptomatic and had an increased risk of spontaneous rupture and bleeding. This evidence concerns the gene PMEL and angiomyolipoma.